リコンビナント
RabMAb

Anti-Ras 抗体 [EPR3255] (ab108602)

ab108602 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab108602 は 5 報の論文で使用されています。

  • Jin T  et al. RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition. Nat Commun 8:1211 (2017). PubMed: 29084939
  • Shin SM  et al. Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration. Nat Commun 8:15090 (2017). ICC/IF . PubMed: 28489072
  • Li W  et al. The association between expressions of Ras and CD68 in the angiogenesis of breast cancers. Cancer Cell Int 15:17 (2015). IHC-P ; Human . PubMed: 25685069
  • Sos ML  et al. Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors. Cell Rep 8:1037-48 (2014). IP, WB . PubMed: 25127139
  • Ostrem JM  et al. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503:548-51 (2013). Human . PubMed: 24256730

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録